NJEDA Board Approves Implementation of GROW NJ Accommodations to Address COVID-19 Impacts
TRENTON, N.J. (February 10, 2021) – The New Jersey Economic Development Authority (NJEDA) Board of Directors today approved the implementation of new accommodations for businesses that had previously been approved for Grow New Jersey (Grow NJ) awards. These accommodations were created by the Economic Recovery Act of 2020 (ERA), signed by Governor Phil Murphy on January 7, 2021, which amended the Grow NJ Act to provide flexibility to businesses that had been impacted by the changed economic and health circumstances due to the COVID-19 Health Emergency.
“Businesses of all sizes have endured innumerable challenges caused by the COVID-19 outbreak. Governor Murphy’s holistic, proactive response has addressed many of those challenges, but businesses still need flexibility to adapt to the new circumstances the pandemic has created,” said NJEDA Chief Executive Officer Tim Sullivan. “Providing businesses that were approved for Grow NJ tax credits that have had to adjust their plans to comply with public health guidance some additional flexibility will enable them to follow through on their commitments to New Jersey’s workers and communities without jeopardizing the incentives for which they were approved.”
The amendments to Grow NJ included in the ERAinclude:
- A business may choose to waive its obligations under the incentive agreement for the 2020 and 2021 tax periods and instead extend the incentive agreement by a corresponding period of time.
- A business may terminate its Grow New Jersey agreement due to the COVID-19 pandemic any time before December 31, 2022 without the NJEDA recapturing previously distributed tax credits.
- A business may amend its Grow NJ agreement to reset its employment requirements starting with 2020 provided the incentive award is recalculated and reduced to reflect the lower employment.
To verify that companies requesting to terminate their Grow NJ awards under the new COVID-related provision are doing so due to the COVID-19 public health emergency, NJEDA staff will require the applicant to submit an explanation of the impact of the public health emergency. Additionally, for all these new ERA provisions, the CEO or an equivalent officer must certify that no events of default have occurred prior to EO 103 (Health Emergency) in March 2020 and that the facility that was approved for tax credits remains operational. Fees for these amendments will follow existing Grow NJ program regulations.
Applicants seeking additional information about the Grow NJ modifications should contact NJEDA Customer Care at CustomerCare@njeda.com.
About the New Jersey Economic Development Authority
To learn more about NJEDA resources for businesses call NJEDA Customer Care at 609-858-6767 or visit https://www.njeda.gov and follow @NewJerseyEDA on Facebook, Twitter, Instagram, and LinkedIn.
###
Related Content
September 13, 2024
NJEDA Board Approves NJ Innovation Evergreen Fund Investment into Princeton-Based Life Sciences Company
TRENTON, N.J. (September 13, 2024) – This week, the New Jersey Economic Development Authority (NJEDA) Board approved the fourth investment from the New Jersey Innovation Evergreen Fund (NJIEF) into an emerging Princeton-based life sciences company, RICOVR Healthcare, which is developing a rapid diagnostic test for cannabis use.
September 13, 2024
NJEDA Board Awards Tax Credits to Assist Rehabilitation of Historic Schwehm Building in Atlantic City
TRENTON, N.J. (September 13, 2024) – Earlier this week, the New Jersey Economic Development Authority (NJEDA) Board approved a tax credit award of up to $8 million to rehabilitate the underutilized Schwehm Building in downtown Atlantic City under the Historic Property Reinvestment Program (HPRP).
September 12, 2024
Manufacturing Voucher Program Phase III Approved by NJEDA Board
TRENTON, N.J. (September 12, 2024) – Yesterday, the New Jersey Economic Development Authority (NJEDA) Board approved Phase III of the Manufacturing Voucher Program (MVP), dedicating an additional $10 million to support manufacturers access to new equipment.